Gastrointestinal symptoms are highly prevalent, but many people who have them will have
no organic explanation for their symptoms. Most of these people will be labelled as having a …

Importance The prevalence of irritable bowel syndrome (IBS) in the United States is between
7% and 16%, most common in women and young people, with annual direct costs estimated …

Irritable bowel syndrome (IBS) is a highly prevalent, chronic disorder that significantly
reduces patients' quality of life. Advances in diagnostic testing and in therapeutic options for …

Irritable bowel syndrome (IBS) remains one of the most common gastrointestinal disorders
seen by clinicians in both primary and secondary care. Since publication of the last British …

Background & Aims Irritable bowel syndrome (IBS) is a common disorder of gut–brain
interaction associated with significant disease burden. This American Gastroenterological …

Background & Aims Irritable bowel syndrome (IBS) is a common functional gastrointestinal
disorder associated with significant disease burden. This American Gastroenterological …

OBJECTIVES: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder that is
thought to be due to a disorder of brain–gut function. Drugs acting centrally, such as …

Functional dyspepsia (FD) is a common disorder of gut–brain interaction, affecting
approximately 7% of individuals in the community, with most patients managed in primary …

Irritable bowel syndrome (IBS) affects 5–10% of the global population. Up to one-third of
people with IBS also experience anxiety or depression. Gastrointestinal and psychological …

Brain–gut interactions affect psychological wellbeing and symptom reporting in functional
gastrointestinal disorders; the presence of anxiety or depression is associated with the …